Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Jeffery J. Auletta(NHS Blood and Transplant), Bronwen E. Shaw(Medical College of Wisconsin), Marcie Riches(University of North Carolina at Chapel Hill), Rachel Cusatis(Medical College of Wisconsin), Waleska S. Pérez(Medical College of Wisconsin), Kristin Page(Medical College of Wisconsin), Mehdi Hamadani(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rafeek A. Yusuf(National Marrow Donor Program), Debra Christianson(National Marrow Donor Program), Stephanie J. Lee(Fred Hutch Cancer Center), Mary Hengen(National Marrow Donor Program), Mary Eapen(Medical College of Wisconsin), Patricia Steinert(Medical College of Wisconsin), Yung‐Tsi Bolon(National Marrow Donor Program), Heather E. Stefanski(National Marrow Donor Program), Wael Saber(Medical College of Wisconsin), Caitrin Bupp(National Marrow Donor Program), Stephen R. Spellman(National Marrow Donor Program), Jianqun Kou(East Tennessee State University), J. Douglas Rizzo, Eileen Tuschl(Medical College of Wisconsin), Marcelo C. Pasquini(Medical College of Wisconsin), Amy Moskop(Medical College of Wisconsin), Larisa Broglie(Medical College of Wisconsin), Mei‐Jie Zhang(Medical College of Wisconsin), Min Chen(Allen Institute for Brain Science), Rachel Phelan(Medical College of Wisconsin), Steven M. Devine(National Marrow Donor Program)
Cited by 68
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664